Bacillus coagulans SNZ-1969 and Reduced Susceptibility to Infection

• Testing the Immunomodulatory Effects of Probiotic Bacillus coagulans SNZ 1969® in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.

  • 2025-10-18
  • RCT · n = 7
  • Cureus 17(10)
  • • Krishna Murthy D
    • Raunak J Soman
    • Dhruv Soman
    • Kishan Pv

  • PubMed: 41262831
  • DOI: 10.7759/cureus.94845

  13 Insights on

  • Reduced Susceptibility to Infection

  • High evidence

  "Secondary analyses showed numerical reduction trends in upper respiratory tract infections (20% versus 32%; p = 0.11), gastrointestinal infections (8% versus 28%), and total illness days (23 days versus 35 days), favoring the probiotic group, though statistical significance was not achieved."

  Effect

  Beneficial

  Effect size

  Small

  Significant

  No